The key benchmark indices extended gains and hit fresh intraday high in mid-afternoon trade. The Nifty traded above 17,900 level after hitting the day's low at 17,800.05 in early trade. Bank stocks witnessed decent buying demand.
At 14:30 IST, the barometer index, the S&P BSE Sensex, was up 593.11 points or 0.98% to 61,024.95. The Nifty 50 index advanced 164.40 points or 0.93% to 17,935.30.
In the broader market, the S&P BSE Mid-Cap index declined 0.40% while the S&P BSE Small-Cap index shed 0.47%.
The market breadth was weak. On the BSE, 1,292 shares rose and 2,138 shares fell. A total of 129 shares were unchanged.
Numbers to track:
The yield on India's 10-year benchmark federal paper advanced 0.10% to 7.376 from 7.366 previous trading session.
In the foreign exchange market, the rupee edged lower against the dollar. The partially convertible rupee was hovering at 82.74, compared with its close of 82.70 during the previous trading session
MCX Gold futures for 5 April 2023 settlement rose 0.44% to Rs 56746.
The United States 10-year bond yield declined 0.83% to 3.688.
The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, was down 0.16% to 103.18.
In the commodities market, Brent crude for April 2023 settlement declined 0.61 cents or 0.70% to $86 a barrel.
Buzzing Index:
The Nifty Bank index advanced 0.82% to 41,621.55. The index had declined 0.67% to end at 41,282.20 in the past trading session.
Bank of Baroda (up 2.09%), ICICI Bank (up 1.81%), Axis Bank (up 0.97%), HDFC Bank (up 0.61%), Punjab National Bank (up 0.6%), State Bank of India (up 0.09%) and IndusInd Bank (up 0.07%) advanced.
On the other hand, Federal Bank (down 0.84%), Bandhan Bank (down 0.67%) and IDFC First Bank (down 0.44%) edged lower.
Stocks in Spotlight:
Mirza International surged 12.49% .The company's consolidated net profit rose 31.1% to Rs 57.58 crore on 0.9% increase in revenue from operations to Rs 594.88 crore in Q3 December 2022 over Q3 December 2021.
Bharat Forge slipped 2.02% .The company reported 14.3% drop in standalone net profit to Rs 289.2 crore in Q3 FY23 from Rs 337.4 crore in Q3 FY22. Total revenue rose by 21.8% YoY to Rs 1,952.1 crore during the quarter
Ipca Laboratories declined 0.74%. The company's consolidated net profit tumbled 45.25% to Rs 107.84 crore in Q3 FY23 as compared to Rs 196.96 crore reported in Q3 FY22. Revenue from operations rose 8.08% to Rs 1,546 crore during the quarter as against Rs 1,430.47 crore recorded in the corresponding quarter last year.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
